On the occasion of their annual the“Prescrire” magazine recognized Les Laboratoires Ethypharm
Since January 1981, Prescrire a French monthly independent medical journal publishes the news of diseases, drugs and medical techniques and technologies.
Its purpose is to provide to and through healthcare professionals and patients, the clear, synthetic and reliable information they need on drugs, diagnostic and therapeutic strategies.
On the occasion of their annual awards by the end of January, the “Prescrire” magazine recognized Les Laboratoires Ethypharm with two distinctions for Prenoxad® kit, indicated in the management of opiate overdoses.
Les Laboratories Ethypharm were named in the category of « honourable company », which reflects how each firm assumes responsibility for sharing information with the journal.
Although no “Gold Pill” was given this year, the naloxone kits were particularly highlighted during this edition. PRENOXAD (which launch is planned in Q1/Q2 2019), was named in this category.
Even if their impact is considered to be modest, the drugs named in the rankings help to improve the means of taking care of patients.
2019 marks a turning point with an acceleration of the availability of addiction medicines in France. The wide availability of naloxone is one of the priority guidelines set by the health authorities in France. The obtaining of two awards given by the independent journal “Prescrire”, testifies Ethypharm’s commitment in this field to reduce risk and damage.